Desk› Healthcare› Sai Parenterals Ltd

Sai Parenterals Ltd

BSE 544742 SAIPARENT INE0H9F01037

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

27 filings · 11 material · busiest 2026-08-11

What it files

Analyst / Investor Meet7 Press Release3 Order / Contract2 Newspaper Publication2 AGM / EGM2 Change in Management2 Annual Report1 Concall Transcript1

Filings

27 in the window

25 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Intimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August, 2026

Company Update / Analyst / Investor Meet View filing →
25 August 2026

Order / Contract

Award_of_Order_Receipt_of_Order

Announcement under Regulation 30 (LODR)

Company Update / Award of Order / Receipt of Order View filing →
25 August 2026

Press Release

Press Release / Media Release

Announcement under Regulation 30 (LODR)

Company Update / Press Release / Media Release View filing →
20 August 2026

Newspaper Publication

Newspaper Publication

Submission of Newspaper Publication in Form PAS-1 for change or variation in the objects of utilisation of IPO Proceeds.

Company Update / Newspaper Publication View filing →
20 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication of Notice of 25th Annual General Meeting of the Comapny for FY2025-26.

Company Update / Newspaper Publication View filing →
19 August 2026

AGM / EGM

Notice Of 25Th Annual General Meeting

Notice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September, 2026.

AGM/EGM / AGM View filing →
19 August 2026

Annual Report

Reg. 34 (1) Annual Report.

Annual Report of the company for FY 2025-26

Others / Reg. 34 (1) Annual Report View filing →
19 August 2026

AGM / EGM

Book Closure Intimation For 25Th Annual General Meeting

Book closure intimation for 25th Annual General Meeting

AGM/EGM / AGM View filing →
18 August 2026

Concall Transcript

Earnings Call Transcript

Transcript of Earnings Call held on 12th August, 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.

Company Update / Earnings Call Transcript View filing →
12 August 2026

Investor Presentation

Investor Presentation

Investor Presentation Q1 FY 2027

Company Update / Investor Presentation View filing →
12 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio Recording of the Earnings call held on 12th August, 2026

Company Update / Analyst / Investor Meet View filing →
11 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August, 2026.

Outcome of Board Meeting held on 11th August, 2026 at the registered office of the company.

Board Meeting / Outcome of Board Meeting View filing →
11 August 2026

Results

Financial Results For The Quarter Ended 30.06.2026.

Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.

Result / Financial Results View filing →
11 August 2026

Change in Management

Change in Management

Announcement under Regulation 30 (LODR)- Change in Management

Company Update / Change in Management View filing →
11 August 2026

Other Update

Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Statement on deviation or varition of funds

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
11 August 2026

Press Release

Press Release / Media Release

Press Release

Company Update / Press Release / Media Release View filing →
7 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

The Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August, 2026.

Company Update / Analyst / Investor Meet View filing →
4 August 2026

Board Meeting

Board Meeting Intimation for Meeting Proposed To Be Held On 11Th August, 2026.

Sai Parenterals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results ....

Board Meeting / Board Meeting View filing →
6 July 2026

Outcome

Board Meeting Outcome for Outcome Of The Board Meeting

Outcome of the Board Meeting

Others / Outcome without intimation View filing →
6 July 2026

Change in Management

Change in Management

Outcome of Board Meeting

Company Update / Change in Management View filing →
1 July 2026

Order / Contract

Award_of_Order_Receipt_of_Order

Announcement under Regulation 30 (LODR)

Company Update / Award of Order / Receipt of Order View filing →
1 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Company Update / Analyst / Investor Meet View filing →
1 July 2026

Press Release

Press Release / Media Release

Press Release

Company Update / Press Release / Media Release View filing →
30 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Company Update / Analyst / Investor Meet View filing →
30 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Company Update / Analyst / Investor Meet View filing →
30 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Company Update / Analyst / Investor Meet View filing →
29 June 2026

Trading Window

Closure of Trading Window

Closure of trading window for the quarter ending on 30th June, 2026

Insider Trading / SAST / Closure of Trading Window View filing →